ScienceBEAT awarded the Golden Practice 2023
- Lek, a Sandoz company, was awarded the Golden Practice 2023 prize for its ScienceBEAT event. The event is part of the Golden Thread project.
- ScienceBEAT is a scientific and professional event aimed at connecting young talents in Slovenia and internationally with world-renowned scientists and innovators.
- The Golden Practice Award recognizes organizations that use innovative approaches to grow and develop their people, leading by example and inspiring others.
Lek, a Sandoz company, won the Golden Practice Award at yesterday's Golden Thread Awards ceremony, presented by the Dnevnik daily for innovative and efficient HR practices. The award was won by ScienceBEAT, an event that focuses on a sustainable strategy to attract new talent by encouraging young people to pursue scientific careers in the pharmaceutical industry and providing access to a global network of scientific and professional excellence.
ScienceBEAT was created with a vision to share the knowledge of leading experts, bringing together the best the world has to offer in science and entrepreneurship. It is the result of an excellent collaboration between business and academia, to which Lek has devoted a great deal of attention since its inception. More than 100 young talents participated in the first ScienceBEAT, from which we selected the top 28 from Slovenia, Croatia, Serbia, Bosnia and Herzegovina, Poland and Kazakhstan based on their academic excellence, extracurricular activities and scientific achievements. "With ScienceBEAT, we want to further strengthen our partnership with the academic sphere and offer exceptional talent a unique opportunity to connect with world-renowned scientists, researchers and entrepreneurs. This sends a message to the most promising talent in the region and beyond that as an employer we offer a highly innovative and stimulating working environment where they can continue to develop after graduation. They are not limited to Slovenia, but can take advantage of being part of the global Sandoz system for their career development," said Robert Ljoljo, President of the Lek Board of Management and Sandoz Country President Slovenia, upon receiving the award.
Jure Vajs, Head Strategic Programs at Lek and head of the ScienceBEAT organizational committee, said: “ScienceBEAT is a unique opportunity for young talent in Slovenia. It is the result of the collaborative work of Lek and its outstanding partners, and lays the foundations for new, forward-looking ways of working and collaborating between science and business in Slovenia. Our goal is for ScienceBEAT to become the region's leading high-tech, science and business event, and a career gateway to a global network of excellence in science and entrepreneurship”.
The Golden Practice 2023 is further confirmation of Lek's excellent HR practices, which have been recognized by the independent Top Employer Institute, which awarded Lek the prestigious international Top Employer 2024 certificate for best employer. This coveted title is in addition to the title of Most Reputable Employer, which Lek received from MojeDelo.com in 2023, the TOP Investor in Education certificate, and other human resources awards.
The Golden Practice Award is presented by Dnevnik, the organizer of the Golden Thread media and research project. This award recognizes organizations with innovative, effective and creative approaches that are based on the objectives of the organization's strategy, are proactive, inclusive and add value to the organization.
For more information about the event, visit www.lek.si/en/careers/sciencebeat/.
About Lek
Lek, a Sandoz company, is the first and oldest pharmaceutical company in Slovenia, developing, manufacturing and marketing effective, safe and high-quality generics and biosimilars for patients around the world. Our work is guided by strong ethical standards, innovative thinking and the breakthrough achievements of our world-class professionals. With more than 3,700 associates, we have been actively shaping the Slovenian, European and global research and development landscape for decades. We are building a culture of open dialog, and we proudly and responsibly hold the title of most reputable employer in Slovenia.
About Sandoz
Sandoz (SIX: SDZ; OTCQX: SDZNY) is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work together to ensure 800 million patient treatments are provided by Sandoz, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1500 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the first biosimilar in 2006. In 2023, Sandoz recorded sales of USD 9.6 billion.
Disclaimer
This Media Release contains forward-looking statements which offer no guarantee with regard to future performance. These statements are made on the basis of management’s views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside of the control of Sandoz. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. Each forward-looking statement speaks only as of the date of the particular statement, and Sandoz undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law.
Photo for print
Photo for print
Previous press releases
Contact us
Gregor Makuc
T: +386 1 580 22 43
info.lek@sandoz.com